These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 1642482)
1. Aryl phosphate derivatives of AZT retain activity against HIV1 in cell lines which are resistant to the action of AZT. McGuigan C; Pathirana RN; Mahmood N; Devine KG; Hay AJ Antiviral Res; 1992 Apr; 17(4):311-21. PubMed ID: 1642482 [TBL] [Abstract][Full Text] [Related]
2. Intracellular delivery of bioactive AZT nucleotides by aryl phosphate derivatives of AZT. McGuigan C; Pathirana RN; Balzarini J; De Clercq E J Med Chem; 1993 Apr; 36(8):1048-52. PubMed ID: 8478904 [TBL] [Abstract][Full Text] [Related]
3. Phosphate derivatives of AZT display enhanced selectivity of action against HIV 1 by comparison to the parent nucleoside. McGuigan C; Nickson C; Petrik J; Karpas A FEBS Lett; 1992 Sep; 310(2):171-4. PubMed ID: 1397268 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and anti-HIV activity of some novel lactyl and glycolyl phosphate derivatives. McGuigan C; Nickson C; O'Connor TJ; Kinchington D Antiviral Res; 1992 Mar; 17(3):197-212. PubMed ID: 1567187 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and anti-HIV activity of some novel diaryl phosphate derivatives of AZT. McGuigan C; Davies M; Pathirana R; Mahmood N; Hay AJ Antiviral Res; 1994 May; 24(1):69-77. PubMed ID: 7944314 [TBL] [Abstract][Full Text] [Related]
6. Amino acid phosphoramidate monoesters of 3'-azido-3'-deoxythymidine: relationship between antiviral potency and intracellular metabolism. Chang S; Griesgraber GW; Southern PJ; Wagner CR J Med Chem; 2001 Jan; 44(2):223-31. PubMed ID: 11170632 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-HIV activity of some haloalkyl phosphoramidate derivatives of 3'-azido-3'-deoxythymidine (AZT): potent activity of the trichloroethyl methoxyalaninyl compound. McGuigan C; Devine KG; O'Connor TJ; Kinchington D Antiviral Res; 1991; 15(3):255-63. PubMed ID: 1888176 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and anti-HIV evaluation of some phosphoramidate derivatives of AZT: studies on the effect of chain elongation on biological activity. Curley D; McGuigan C; Devine KG; O'Connor TJ; Jeffries DJ; Kinchington D Antiviral Res; 1990 Dec; 14(6):345-56. PubMed ID: 2088210 [TBL] [Abstract][Full Text] [Related]
9. Evidence of in vitro development of drug resistance to azidothymidine in T-lymphocytic leukemia cell lines (Jurkat E6-1/AZT-100) and in pediatric patients with HIV-1 infection. Avramis VI; Kwock R; Solorzano MM; Gomperts E J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1287-96. PubMed ID: 8254464 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and antiviral activity of 3'-azido-3'-deoxythymidine triphosphate distearoylglycerol: a novel phospholipid conjugate of the anti-HIV agent AZT. van Wijk GM; Hostetler KY; Kroneman E; Richman DD; Sridhar CN; Kumar R; van den Bosch H Chem Phys Lipids; 1994 Apr; 70(2):213-22. PubMed ID: 8033292 [TBL] [Abstract][Full Text] [Related]
11. AZT and AZT-monophosphate prodrugs incorporating HIV-protease substrate fragment: synthesis and evaluation as specific drug delivery systems. Liotard JF; Mehiri M; Di Giorgio A; Boggetto N; Reboud-Ravaux M; Aubertin AM; Condom R; Patino N Antivir Chem Chemother; 2006; 17(4):193-213. PubMed ID: 17066898 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of novel ether lipid nucleoside conjugates for anti-HIV-1 activity. Piantadosi C; Marasco CJ; Morris-Natschke SL; Meyer KL; Gumus F; Surles JR; Ishaq KS; Kucera LS; Iyer N; Wallen CA J Med Chem; 1991 Apr; 34(4):1408-14. PubMed ID: 1901911 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiretroviral evaluation of new alkoxy and aryloxy phosphate derivatives of 3'-azido-3'-deoxythymidine. Tsotinis A; Calogeropoulou T; Koufaki M; Souli C; Balzarini J; De Clercq E; Makriyannis A J Med Chem; 1996 Aug; 39(17):3418-22. PubMed ID: 8765527 [TBL] [Abstract][Full Text] [Related]
15. New lipophilic alkyl/acyl dinucleoside phosphates as derivatives of 3'-azido-3'-deoxythymidine: inhibition of HIV-1 replication in vitro and antiviral activity against Rauscher leukemia virus infected mice with delayed treatment regimens. Schwendener RA; Gowland P; Horber DH; Zahner R; Schertler A; Schott H Antiviral Res; 1994 May; 24(1):79-93. PubMed ID: 7944315 [TBL] [Abstract][Full Text] [Related]
16. AZT-5'-(p-bromophenyl methoxyalaninyl phosphate) as a potent and non-toxic anti-human immunodeficiency virus agent. Jan ST; Zhu Z; Tai HL; Shih MJ; Venkatachalam TK; Uckun FM Antivir Chem Chemother; 1999 Jan; 10(1):47-52. PubMed ID: 10079879 [TBL] [Abstract][Full Text] [Related]
18. Aryl phosphate derivatives of bromo-methoxy-azidothymidine are dual-function spermicides with potent anti-human immunodeficiency virus. D'Cruz OJ; Venkatachalam TK; Zhu Z; Shih MJ; Uckun FM Biol Reprod; 1998 Sep; 59(3):503-15. PubMed ID: 9716547 [TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT). Periclou AP; Nandy P; Avramis VI In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of 3'-azido-3'-deoxythymidine correlates with 3'-azidothymidine-5'-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3'-azidothymidine-5'-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells. Törnevik Y; Ullman B; Balzarini J; Wahren B; Eriksson S Biochem Pharmacol; 1995 Mar; 49(6):829-37. PubMed ID: 7702641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]